These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12595587)

  • 41. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
    Kim HY; Lee HG; Kim DS
    J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease.
    Nagata S; Yamashiro Y; Maeda M; Ohtsuka Y; Yabuta K
    Pediatr Res; 1993 Jun; 33(6):557-63. PubMed ID: 8378111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a superantigen mediated process in Kawasaki disease.
    Curtis N; Zheng R; Lamb JR; Levin M
    Arch Dis Child; 1995 Apr; 72(4):308-11. PubMed ID: 7763061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection.
    Tsao N; Cheng MH; Yang HC; Wang YC; Liu YL; Kuo CF
    PLoS One; 2013; 8(1):e55028. PubMed ID: 23383045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification & characterisation of the two novel streptococcal pyrogenic exotoxins SPE-L & SPE-M.
    Thomas P; Webb PD; Handley V; Fraser JD
    Indian J Med Res; 2004 May; 119 Suppl():37-43. PubMed ID: 15232160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The superantigenic activity of streptococcal pyrogenic exotoxin B is independent of the protease activity.
    Eriksson A; Norgren M
    FEMS Immunol Med Microbiol; 1999 Sep; 25(4):355-63. PubMed ID: 10497866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C.
    Yamaoka J; Nakamura E; Takeda Y; Imamura S; Minato N
    Infect Immun; 1998 Oct; 66(10):5020-6. PubMed ID: 9746612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reevaluation of streptococcal infection in the pathogenesis of Kawasaki disease.
    Shen CT; Wu HY; Wang NK; Huang CS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(3):144-50. PubMed ID: 2275373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Streptococcal superantigens: categorization and clinical associations.
    Commons RJ; Smeesters PR; Proft T; Fraser JD; Robins-Browne R; Curtis N
    Trends Mol Med; 2014 Jan; 20(1):48-62. PubMed ID: 24210845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective modulation of superantigen-induced responses by streptococcal cysteine protease.
    Kansal RG; Nizet V; Jeng A; Chuang WJ; Kotb M
    J Infect Dis; 2003 Feb; 187(3):398-407. PubMed ID: 12552423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kawasaki disease and toxic shock syndrome--at last the etiology is clear?
    Curtis N
    Adv Exp Med Biol; 2004; 549():191-200. PubMed ID: 15250533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonneutralizing antibody to erythrogenic toxin A alpha(NY5ETA) in human sera.
    Nakano S; Abe Y; Kamezawa Y; Nakahara T
    Adv Exp Med Biol; 1997; 418():923-4. PubMed ID: 9331800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte subpopulations in Kawasaki disease.
    Shannon K; Fink CW; Buchanan GR; Punaro M; Stastny P
    Clin Exp Rheumatol; 1983; 1(1):59-62. PubMed ID: 6398155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.
    Mascini EM; Jansze M; Verhoef J; van Dijk H
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):977-80. PubMed ID: 10548596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. IX. Quantitation by ELISA of streptococcal pyrogenic exotoxin in the serum of MCLS patients.
    Kawai M; Osawa N; Yamaura N; Ikewaki N; Yashiro K; Hiraishi S; Watanabe M; Akiyama T
    Acta Paediatr Jpn; 1989 Oct; 31(5):529-36. PubMed ID: 2515729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probable role of Streptococcus pyogenes in Kawasaki disease.
    Akiyama T; Yashiro K
    Eur J Pediatr; 1993 Feb; 152(2):82-92. PubMed ID: 8444235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.
    Tomai MA; Schlievert PM; Kotb M
    Infect Immun; 1992 Feb; 60(2):701-5. PubMed ID: 1530928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.
    Lee HH; Park IH; Shin JS; Kim DS
    Yonsei Med J; 2009 Aug; 50(4):493-504. PubMed ID: 19718396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease.
    Nagata S; Yamashiro Y; Ohtsuka Y; Shimizu T; Sakurai Y; Misawa S; Ito T
    Immunology; 2009 Dec; 128(4):511-20. PubMed ID: 19950419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sister chromatid exchange-inducing DNA lesions and depression of activation markers on the surface of cultured peripheral blood mononuclear cells after the addition of streptococcal pyrogenic exotoxins A and C.
    Büssing A; Klotz M; Suzart K; Efferth T; Gerlach D; Schnitzler N; Osieka R; Schweizer K; Kaufhold A
    Med Microbiol Immunol; 1995 Aug; 184(2):87-96. PubMed ID: 7500916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.